Why the study?
Are baseline serum albumin levels associated with angiographic no-reflow in STEMI patients undergoing primary PCI?
Are baseline serum albumin levels associated with angiographic no-reflow in STEMI patients undergoing primary PCI?
Lower admission serum albumin levels are associated with an increased risk of angiographic no-reflow in STEMI patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
May aid no-reflow risk stratification in STEMI PCI; hypothesis-generating, requires prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Acet et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: